INC Research

MDS Pharma Services to Expand Early-Stage Operations in Taiwan

Thursday, June 11, 2009 07:50 AM

MDS Pharma Services, the CRO division of MDS, is undertaking a major renovation and expansion of its discovery operation in Taiwan as part of the company's recently announced plan to focus on early-stage clinical research.

More... »

MDS Pharma to Focus on Early Stage, Selling Late Stage to INC Research for $50M

Monday, June 8, 2009 08:49 AM

MDS, the parent company of MDS Pharma Services, has entered into an agreement with INC Research to sell off MDS' phase II through IV contract research business for $50 million in order to focus on early-stage clinical development.

More... »

INC Research Plans to Acquire Late Stage Division of MDS for $50M

Tuesday, June 2, 2009 07:00 AM

Raleigh, N.C.-based contract research organization (CRO) INC Research entered into an agreement to acquire the phase II through IV operations of MDS Pharma Services, the clinical development division of MDS, for $50 million.

More... »

INC Research Drops 3% of U.S. Workforce

Monday, July 14, 2008 10:50 AM

In an effort to “realign” its headcount with the company’s “business needs,” Raleigh, N.C.-based contract research organization (CRO) INC Research laid off 34 employees—or 3%—within its U.S. clinical operations. Internet news outlet WRAL.com in Raleigh reported Trisha Vonder Reith, INC’s executive director of corporate communications, as stating:

More... »

INC Research Acquires PRC; Expands Late Stage Capabilities

Wednesday, September 27, 2006 10:48 AM

INC Research, a Raleigh, N.C.-based contract research organization (CRO),has acquired Pharmaceutical Research (PRC), a late stage–focused CRO based in Hatboro, Penn. INC was actively searching for an opportunity to grow in the area of late stage trials. The acquisition allows INC to expand its phase IIIb/IV capabilities. About 90% of INC’s business is in the phase I to III market, while 70% of the trials that PRC services are in phase IIIb/IV. “PRC has a strong reputation in that area, and so they were an obvious choice for us to talk to. It was also culturally similar with some great goals for growth,” John Potthoff, president and chief operating officer, INC Research told CWWeekly.

More... »